There is a role for imaging in managing CLL when there is an indication, but no role for “routine” imaging as Dr. Lamanna explains at iwCLL 2019 in Scotland in the article by Tom Henry, the CLL Society’s pharmacist.
The European Research Initiative on CLL (ERIC) held their first international meeting, NEW FRONTIERS IN CLL RESEARCH, in Barcelona, Spain Oct. 25-27, 2018. ERIC is a smaller meeting attended mostly by researchers who are primarily focused on CLL. Every session is on CLL, so unlike ASH, there is no downtime
The abnormal white blood cells or “leukemic cells” produced in chronic lymphocytic leukemia (CLL) can reside for years in various parts of the body, slowly and discretely accumulating in bone marrow, blood, or lymph nodes. Taking years to become detectable and unlike other types of cancers which produce solid
The following provides the very basics of bone marrow evaluation for patients with CLL and SLL. In untreated patients with CLL, the bone marrow virtually always has leukemia cells present, including at initial diagnosis.
The Risk Of Secondary Cancer Associated With > 8 CT Scans In Patients With NHL (Non Hodgkins Lymphoma) Take Away Points: Although CLL is a form of NHL, this study is in a different demographic with a different disease and different treatment. More than 8 CT Scan was associated
This is a lengthy and detailed review of a complicated subject, full of excellent references, representing the extensive research and the strong and well reasoned opinions of the writer, Wayne Wells AKA WWW. WWW is a well respected contributer to CLL patient forums. The reader may want to chew
Takeaway Points: To diagnose chronic lymphocytic leukemia (CLL), there needs to be ≥5000 monoclonal (genetically identical) B-lymphocytes (a type of white blood cell) in the blood for the duration of at least three months. The clonal nature of the circulating B-lymphocytes should be confirmed by flow cytometry (a test
The diagnosis of SLL requires the finding of an enlarged lymph node or nodes and/or an enlarged spleen with less than 5000 B-lymphocytes per microliter of blood (the absolute lymphocyte count or ALC is <5.0). Once more than 5,000 cancerous B-lymphocytes per microliter have spilled over into the blood,